Living Donors Online Message Board
Living Donation Discussion and News => Living Donation in the News => Topic started by: Clark on February 27, 2021, 04:32:08 PM
-
https://onlinelibrary.wiley.com/doi/full/10.1111/tri.13840?campaign=wolacceptedarticle (https://onlinelibrary.wiley.com/doi/full/10.1111/tri.13840?campaign=wolacceptedarticle)
The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient – One year into the pandemic
Pascale Khairalla (https://onlinelibrary.wiley.com/action/doSearch?ContribAuthorStored=Khairallah%2C+Pascale)h, et al.
First published: 05 February 2021https://doi.org/10.1111/tri.13840 (https://doi.org/10.1111/tri.13840)
Summary
The COVID‐19 pandemic has significantly changed the landscape of kidney transplantation in the United States and worldwide. In addition to adversely impacting allograft and patient survival in postkidney transplant recipients, the current pandemic has affected all aspects of transplant care, including transplant referrals and listing, organ donation rates, organ procurement and shipping, and waitlist mortality. Critical decisions were made during this period by transplant centers and individual transplant physicians taking into consideration patient safety and resource utilization. As countries have begun administering the COVID vaccines, new and important considerations pertinent to our transplant population have arisen. This comprehensive review focuses on the impact of COVID‐19 on kidney transplantation rates, mortality, policy decisions, and the clinical management of transplanted patients infected with COVID‐19.
-
I thought this part was interesting:
Ongoing barriers to living‐donor transplantation include center concerns for donor and recipient safety, fewer donor inquiries, staff limitations, and government restrictions. With more than 42,000,000 people worldwide who have recovered from COVID‐19 to date, concern about limited data regarding the safety of organ donation from donors with previous infection may also be a contributing factor to reducing the donor pool. Recent American Society of Transplantation guidance note that “given the renal dysfunction associated with SARS‐CoV‐2 infection and unclear long‐term implications thereof, additional evaluation may be required when considering kidney transplantation from living donors with previous COVID‐19”.